Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Zydus granted Orphan Drug Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC)

Posted On: 2021-01-27 23:02:06 (Time Zone: Arizona, USA)


Zydus, a leading discovery based, global pharmaceutical company today announced that United States Food and Drug Administration (USFDA) has granted 'Orphan Drug Designation' (ODD) to Saroglitazar Mg for the treatment of patients with Primary Biliary Cholangitis (PBC). Orphan drug designation provides eligibility for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity upon FDA approval. This follows the grant of 'Fast Track Designation' by the USFDA to Saroglitazar Mg for PBC in December 2020.

Saroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist. Results of PHASE 2, prospective multicentre randomized double-blind, placebo controlled study to evaluate the safety, tolerability and efficacy of Saroglitazar Mg in patients with PRIMARY BILIARY CHOLANGITIS (EPICS) was presented earlier at the Liver Meeting® 2020, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) [ClinicalTrials.gov Identifier: NCT03112681]. The treatment options are still evolving for PBC and Saroglitazar holds immense potential based on its safety and efficacy profile so far. The global market for PBC treatment is expected to grow at a CAGR of 36.3% from 2018 - 2026 and is expected to reach USD 10.8 bn by 2026 as per Coherent market insights.

Speaking on the development, Pankaj R. Patel, Chairman, Zydus Group said, "We are pleased that the USFDA has granted an Orphan Drug Designation apart from the earlier Fast Track Designation to Saroglitazar Mg for the treatment of Primary Biliary Cholangitis (PBC). This underlines the urgent need to address this serious health condition which is an unmet medical need. We are committed in our clinical development efforts to improve the quality of life of patients suffering from PBC with a safe and efficacious treatment."

Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.460 as compared to the previous close of Rs. 466.85. The total number of shares traded during the day was 62386 in over 1582 trades.

The stock hit an intraday high of Rs. 472.55 and intraday low of 460. The net turnover during the day was Rs. 29095696.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

GRM Overseas Limited arm launches SPICES

HDFC Property Ventures Ltd divests stake in Magnum

NITCO Ltd updates on sale of stake in NVVPL

Glenmark receives 'India Pharma Innovation of the Year' Award from the Govt. of India

Mahindra & Mahindra arm completes sale of stake in MFCS and ADPL

Aster Labs to provide Covid-19 RT-PCR test reports with QR codes to citizens travelling to Dubai

Sterlite Power elevates Manish Agarwal as CEO of Infrastructure & Solutions Business

ICRA reaffirms long-term rating of Rashtriya Chemicals and Fertilizers Limited

TCS Among Top 5 Triple-A Trifecta Service Providers: HFS

Max Groups' MaxVIL launches Managed Office Space business 'WorkWell Suites', targets 2 lac sq. ft.

Shri Bajrang Alliance Limited's Agro Division is accredited with BRC CERTIFICATE

Zydus Cadila receives final approval from USFDA for Nortriptyline Hydrochloride Capsules

Gujarat Alkalies and Chemicals Ltd to avail ECB of $70 mn from SBI

L&T Technology Services selected by Airbus for Skywise Partner Programme

Jubilant Industries Ltd updates on restructuring proposal

Sun Pharma Launches Website for its Long-Term Care Portfolio in the U.S.

Angel Broking partners with Vested Finance empowering Indians to invest in US-based stocks

Bharti Airtel announces successful pricing of its $1.25 billion US$ Bond Offering

Max Life receives IRDAI nod for stake sale to Axis Bank Limited

Ashok Leyland Ltd to acquire balance 38% in Hinduja Tech Ltd

Wipro launches Cisco Business Unit marking 25 years of partnership with the company

CSL Signs MoUs with DCI and IHC Holland BV for construction of World-Class Dredgers

Badass Devika wins hearts in ALTBalaji and ZEE5's Dev DD 2, a must watch without doubt

Just Dial launches its exclusive B2B platform, Jd Mart

Indiabulls Real Estate Limited receives CCI, BSE, NSE and SEBI approval for merger

Rajapalayam Mills Limited board to consider terms of rights issue on Feb 27, 2021

Huhtamaki PPL Ltd Q4CY20 PAT slides to Rs. 5.08 crore

Sheshadri Industries Ltd posts Rs. 4.98 crore PAT in Q3FY21

MEP Infrastructure Developers Ltd receives LOA from NHAI for user fee collection at Sergarh Fee Plaza

H.G. Infra Engineering Limited has been declared as L1 bidder by NTPC Limited

Bhakti Gems and Jewellery Ltd launches antique gold jewellery studed with Swarovski Stone

Cyprium Therapeutics and Sentynl Therapeutics sign Development and Asset Purchase Agreement

Narendra Investments (Delhi) Limited board to consider preferential issue and acquisition of assets

Tirupati Starch & Chemicals Ltd board to consider preferential issue offer letter on Feb 25, 2021

Dredging Corporation of India signs MOU with Cochin Shipyard Ltd for construction of dredger

Huhtamaki India Ltd Board recommends dividend of Rs. 3 for CY2020

Aavas Financiers Limited reduces PLR by 15 basis points w.e.f April 1, 2021

IRB Infrastructure Developers Ltd hands over project to MSRDC

SMC Global Securities Ltd. lists its equity shares at stock Exchanges

Nokia and NIIT launch first-of-its-kind 5G certification program over a webinar with COAI

Affle (India) Limited board to consider QIP, fund raising on Feb 27, 2021

Wipro appoints Graziella Neuvéglise as Regional Head and Managing Director, Southern Europe

TCS Named in 2021 Gartner Market Guide for Retail Unified Price, Promotion and Markdown Optimization Applications

Wipro Names René Mulder as Country Head and Managing Director, Switzerland

Godawari Power and Ispat Ltd commences booking export order for high grade Iron Ore Pellets

IDBI Bank withdraws declaration of Nitin Fire Protection Industries Ltd as willful defaulter

IP Rings Ltd opens new facility at Maraimalai Nagar

Spandana Sphoorty Financial Limited approves issue of 12,000 NCDs

Thomas Cook India Launches India's first physical MICE event in partnership with Marriott

Dilip Buildcon Limited declares L1 bidder for two new HAM projects for Bangalore Chennai Expressway



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020